Insider Trading Summary for Acumen Pharmaceuticals, Inc. (ABOS): Year

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
25-Jul-23 4:30 PM View:	21-Jul-23 Purchase $40.00M	Ra Capital Management, LLC Director 10% Owner		Acumen Pharmaceuticals, Inc. - ABOS	53% 9.77M to 14.93M	0	0	--	--	Show Txns Hide Txns

19-Jan-24 7:04 PM View:	18-Jan-24 Sale (Planned) ($10.56K)	Barton Russell Chief Operating Officer		Acumen Pharmaceuticals, Inc. - ABOS	263% 26.7K to 96.87K	0	0	--	--	Show Txns Hide Txns

19-Jan-24 7:05 PM View:	18-Jan-24 Sale (Planned) ($11.60K)	Siemers Eric Chief Medical Officer		Acumen Pharmaceuticals, Inc. - ABOS	340% 26.7K to 117.58K	0	0	--	--	Show Txns Hide Txns

18-Aug-23 6:31 PM View:	17-Aug-23 Planned Option Sale ($272.33K)	Ives Jeffrey L. Director		Acumen Pharmaceuticals, Inc. - ABOS	0% --	0	0	--	--	Show Txns Hide Txns

19-Jan-24 7:07 PM View:	19-Jan-24 Sale (Planned) ($52.75K)	Oconnell Daniel Joseph President and CEO Director		Acumen Pharmaceuticals, Inc. - ABOS	331% 116.69K to 502.49K	0	0	--	--	Show Txns Hide Txns

19-Jan-24 7:05 PM View:	18-Jan-24 Sale (Planned) ($15.72K)	Zuga Matt CFO & Chief Business Officer		Acumen Pharmaceuticals, Inc. - ABOS	93% 109.69K to 211.44K	0	0	--	--	Show Txns Hide Txns

19-Jan-24 7:06 PM View:	19-Jan-24 Sale (Planned) ($31.05K)	Meisner Derek M Chief Legal Officer & Corp Sec		Acumen Pharmaceuticals, Inc. - ABOS	306% 26.8K to 108.87K	0	0	--	--	Show Txns Hide Txns

Buy:	0	--
Sell:	0	--